Photoreceptors derived from iPS cells hold promise for retinal diseases

02/3/2010 | MIT Technology Review

Scientists at the University of Washington in Seattle said they used induced pluripotent stem cell technology to turn stem cells derived from human skin cells into photoreceptors, or light-sensing retinal cells. These iPS cells were transplanted into a mouse retina and found to integrate with nearby tissues. The breakthrough could pave the way for new therapies for retinitis pigmentosa, macular degeneration and other retinal conditions.

View Full Article in:

MIT Technology Review

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC